Global Cord Blood Corporation
Hedge Funds Holdings
Last updated:
Global Cord Blood Corporation‘s stocks are currently a part of 22 hedge funds’ portfolios, which represents 10.66% of the total amount of its stocks outstanding. This makes up a total of 12.96M shares of Global Cord Blood Corporation. Compared to the previous quarter, the number grew by 10.57% or 1.23M shares more. As for the holding position changes, 22.73% (5) of current hedge fund investors increased the number of shares held, 27.27% (6) of current holders sold a part of the shares held, and 31.82% (7) closed the holdings completely. 4 hedge funds are new holders of Global Cord Blood Corporation stock in Q3 2022, it is 18.18% of total holders.
Hedge funds holding Global Cord Blood (Q4 2017 – Q3 2022)
| Q4 2017 | 50 |
|---|---|
| Q1 2018 | 57 |
| Q2 2018 | 45 |
| Q3 2018 | 41 |
| Q4 2018 | 38 |
| Q1 2019 | 36 |
| Q2 2019 | 39 |
| Q3 2019 | 43 |
| Q4 2019 | 34 |
| Q1 2020 | 30 |
| Q2 2020 | 30 |
| Q3 2020 | 26 |
| Q4 2020 | 25 |
| Q1 2021 | 31 |
| Q2 2021 | 30 |
| Q3 2021 | 26 |
| Q4 2021 | 27 |
| Q1 2022 | 29 |
| Q2 2022 | 25 |
| Q3 2022 | 22 |
Hedge funds changes in Global Cord Blood positions (Q4 2017 – Q3 2022)
| Q4 2017 | 14 | 13 | 15 | 15 | -7 |
|---|---|---|---|---|---|
| Q1 2018 | 56 | 0 | 1 | 47 | -47 |
| Q2 2018 | 3 | 12 | 20 | 14 | -4 |
| Q3 2018 | 11 | 13 | 10 | 14 | -7 |
| Q4 2018 | 8 | 8 | 11 | 11 | 0 |
| Q1 2019 | 5 | 15 | 5 | 6 | 5 |
| Q2 2019 | 7 | 7 | 11 | 4 | 10 |
| Q3 2019 | 12 | 7 | 12 | 8 | 4 |
| Q4 2019 | 2 | 9 | 12 | 11 | 0 |
| Q1 2020 | 3 | 7 | 12 | 4 | 4 |
| Q2 2020 | 2 | 10 | 10 | 2 | 6 |
| Q3 2020 | 3 | 6 | 8 | 7 | 2 |
| Q4 2020 | 2 | 7 | 9 | 5 | 2 |
| Q1 2021 | 11 | 6 | 9 | 5 | 0 |
| Q2 2021 | 7 | 8 | 10 | 8 | -3 |
| Q3 2021 | 3 | 9 | 8 | 7 | -1 |
| Q4 2021 | 7 | 9 | 7 | 6 | -2 |
| Q1 2022 | 8 | 9 | 4 | 6 | 2 |
| Q2 2022 | 6 | 6 | 5 | 9 | -1 |
| Q3 2022 | 4 | 5 | 6 | 7 | 0 |
Hedge funds changes in Global Cord Blood stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 454,000 | 0 |
|---|---|---|
| Q1 2018 | 287,000 | 1,014,000 |
| Q2 2018 | 363,000 | 716,000 |
| Q3 2018 | 793,000 | 179,000 |
| Q4 2018 | 118,000 | 81,000 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 64,000 | 0 |
| Q3 2019 | 24,000 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 37,000 |
| Q1 2021 | 49,000 | 101,000 |
| Q2 2021 | 62,000 | 613,000 |
| Q3 2021 | 0 | 201,000 |
| Q4 2021 | 0 | 45,000 |
| Q1 2022 | 204,000 | 123,000 |
| Q2 2022 | 70,000 | 34,000 |
| Q3 2022 | 179,000 | 55,000 |